Article
Hemangioblastomas cause neurogenic polyglobulia
Search Medline for
Authors
Published: | September 16, 2010 |
---|
Outline
Text
Objective: Neurogenic polyglobulia has been reported to occur with CNS hemangioblastomas. Suggested mechanisms of haemoglobin elevation include extramedullary hematopoiesis in the tumor tissue, endocrine paraneoplastic effects and germline mutations of the VHL tumor suppressor gene (causing either Chuvash polycythemia or von Hippel-Lindau disease).
Methods: To clarify the frequency and pathomechanism of polyglobulia in CNS hemangioblastomas, we investigated the preoperative and postoperative haemoglobin levels in a series of 164 patients with hemangioblastomas.
Results: Preoperative haemoglobin levels were available from 163 patients. On average, the preoperative haemoglobin levels of hemangioblastoma patients did not differ significantly from the normal population. However, in 24 patients we observed high preoperative haemoglobin levels (>17 g/dl in male or >15 g/dl in female). 8 of these patients had a pathological elevation of preoperative haemoglobin levels (>18,5 g/dl male or >16,5 g/dl female). In all of these patients, removal of the hemangioblastoma resulted in a permanent cure of polyglobulia. 6 of the 8 patients with pathological haemoglobin elevation carried a germline mutation of the VHL tumor suppressor gene.
Conclusions: Neurogenic polyglobulia occurs in a subset of patients with hemangioblastomas. This phenomenon is observed in patients with VHL germline mutations as well as in patients with sporadic hemangioblastomas. Removal of the tumor results in permanent cure of polyglobulia. Our observations suggest that polyglobulia is an effect by the tumor itself, either due to paraneoplasia or extramedullary hematopoiesis.